Lapatinib plus capecitabine in metastatic human epidermal growth factor receptor 2-positive breast cancer patients that received prior therapy with trastuzumab and pertuzumab: Better option than T-DM1?
Copy For Citation
Altundag K.
JOURNAL OF BUON, vol.22, no.1, pp.281-282, 2017 (SCI-Expanded)
-
Publication Type:
Article / Letter
-
Volume:
22
Issue:
1
-
Publication Date:
2017
-
Journal Name:
JOURNAL OF BUON
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.281-282
-
Hacettepe University Affiliated:
Yes